-
DIRECT MEDICAL COSTS IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): A REAL-WORLD EVIDENCE FROM FOUR CENTERS IN COLOMBIA
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT OF FARICIMAB-TREATED DIABETIC MACULAR EDEMA: A LINKED ANALYSIS OF ADMINISTRATIVE CLAIMS AND IRIS REGISTRY DATA
Mar 18, 2026, 21:38 PM -
EVOLUTION OF HOMOLOGOUS RECOMBINATION REPAIR (HRR) GENETIC TESTING BY RACE AMONG PATIENTS WITH METASTATIC PROSTATE CANCER (MPC) IN A LARGE COMMUNITY ONCOLOGY SETTING IN THE US, 2015-2024
Mar 18, 2026, 21:38 PM -
DEVELOPING DIRECT EQUITY WEIGHTS FOR COST-EFFECTIVENESS ANALYSIS: RESULTS FROM A US-BASED DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
A TOTAL COST OF CARE (TCOC) MODELING TOOL TO EVALUATE SECOND-LINE TREATMENT COSTS FOR PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Mar 18, 2026, 21:38 PM -
USING INDIVIDUAL-LEVEL RACE AND ETHNICITY TO IMPROVE REPRESENTATIVENESS IN CLAIMS-BASED SURVEY SAMPLING FOR A SURVEY OF WOMEN WITH VASOMOTOR SYMPTOMS OF MENOPAUSE
Mar 18, 2026, 21:38 PM -
ACCESS TO ESSENTIAL BREAST AND CERVICAL CANCER MEDICINES IN NIGERIA: A WHO/HAI-BASED EVALUATION OF PRICES, AVAILABILITY, AND AFFORDABILITY
Mar 18, 2026, 21:38 PM -
THERAPEUTIC ROLE OF ALISKIREN MONOTHERAPY IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANTIHYPERTENSIVE AND ANTIPROTEINURIC EFFECTS
Mar 18, 2026, 21:38 PM -
TRENDS IN PREVENTABLE HOSPITALIZATIONS BEFORE AND AFTER MEDICAID EXPANSION IN KENTUCKY
Mar 18, 2026, 21:38 PM -
SAFETY OF BRAND-NAME INFLIXIMAB VERSUS BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE: REAL-WORLD EVIDENCE FROM U.S. CLAIMS DATA
Mar 18, 2026, 21:38 PM -
REAL-WORLD TRANSITION PROBABILITY ANALYSES AMONG UNRESECTABLE LOCALLY ADVANCED (LA) ESOPHAGEAL/GASTROESOPHAGEAL JUNCTION CANCER (EC/GEJC) PATIENTS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY (DCRT) AT COMMUNITY ONCOLOGY CENTERS
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS IN RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS IN A CANADIAN SETTING
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A PROFESSIONAL FRAMEWORK FOR MARKET ACCESS WITHIN THE PHARMACEUTICAL INDUSTRY: A MULTI-METHODS STUDY
Mar 18, 2026, 21:38 PM -
CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE COSTS OF DIFFUSE LARGE B-CELL LYMPHOMA IN COLOMBIA: A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
APPLYING THE POMELO BEST PRACTICES FRAMEWORK TO ENHANCE REPORTING STANDARDS IN PATIENT LISTENING STUDIES FROM SOCIAL MEDIA
Mar 18, 2026, 21:38 PM -
THE DIFFERENTIAL IMPACT OF FAMILY-LEVEL MULTIMORBIDITY ON FINANCIAL HARDSHIP BY INSURANCE STATUS EVIDENCE FROM MEPS 2018-2023
Mar 18, 2026, 21:38 PM -
A SURVEY OF HEOR LEADERS IN PHARMA ABOUT THE STATE OF HEOR
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS, OUTCOMES, AND RESOURCE UTILIZATION IN US ADULTS WITH NF1-PN
Mar 18, 2026, 21:38 PM -
THE BLUES CLOUD THE VIEW: PROXY DEPRESSION IS ASSOCIATED WITH LOWER DYADIC AGREEMENT ON EQ-5D-5L
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND VALUE MATRIX IN A STRUCTURED MODEL FOR THE PROVISION OF IMMUNOBIOLOGIC THERAPIES IN DERMATOLOGY: A REAL-WORLD ANALYSIS
Mar 18, 2026, 21:38 PM
